| 1 | Pyoderma Gangrenosum | 37% |
| 2 | Acne Vulgaris | 31% |
| 3 | Contact Dermatitis | 31% |
| 4 | Eczema | 31% |
| 5 | Erythema Multiforme | 31% |
| 6 | Intertrigo | 31% |
| 7 | Neurodermatitis | 31% |
| 8 | Rhinophyma | 31% |
| 9 | Perioral Dermatitis | 31% |
| 10 | Acne | 31% |
| 11 | Dermatitis, Phototoxic | 30.2% |
| 12 | Pityriasis Lichenoides et Varioliformis Acuta | 30.2% |
| 13 | Pityriasis Lichenoides | 30.2% |
| 14 | Phototoxicity | 30.2% |
| 15 | Abdominal Neoplasms | 28.6% |
| 16 | Breast Diseases | 28.6% |
| 17 | Dermatitis | 28.6% |
| 18 | Exanthema | 28.6% |
| 19 | Facial Dermatoses | 28.6% |
| 20 | Hair Diseases | 28.6% |
| 21 | Hand Dermatoses | 28.6% |
| 22 | Head and Neck Neoplasms | 28.6% |
| 23 | keratoacanthoma | 28.6% |
| 24 | Keratosis | 28.6% |
| 25 | Lupus Erythematosus, Cutaneous | 28.6% |
| 26 | Nail Diseases | 28.6% |
| 27 | Panniculitis | 28.6% |
| 28 | Photosensitivity Disorders | 28.6% |
| 29 | Prurigo | 28.6% |
| 30 | Pyoderma | 28.6% |
| 31 | Rosacea | 28.6% |
| 32 | Systemic Scleroderma | 28.6% |
| 33 | Sebaceous Gland Diseases | 28.6% |
| 34 | Skin Diseases, Vesiculobullous | 28.6% |
| 35 | Skin Ulcer | 28.6% |
| 36 | Soft Tissue Neoplasms | 28.6% |
| 37 | Sweat Gland Diseases | 28.6% |
| 38 | Thoracic Neoplasms | 28.6% |
| 39 | Skin Diseases, Papulosquamous | 28.6% |
| 40 | Skin Diseases, Vascular | 28.6% |
| 41 | Acneiform Eruptions | 28.6% |
| 42 | Ocular Rosacea | 28.6% |
| 43 | Subcorneal pustular dermatosis | 28.6% |
| 44 | Erythematotelangiectatic Rosacea | 28.6% |
| 45 | Papulopustular Rosacea | 28.6% |
| 46 | Chronic Actinic Dermatitis | 28.6% |
| 47 | Morphea | 28.6% |
| 48 | Foot Ulcer | 28.2% |
| 49 | Breast Neoplasms, Male | 28.2% |
| 50 | Triple Negative Breast Neoplasms | 28.2% |
| 51 | Xeroderma Pigmentosum | 27.2% |
| 52 | Dermatitis, Atopic | 26.2% |
| 53 | Epidermolysis Bullosa | 26.2% |
| 54 | Dermatitis, Irritant | 25.4% |
| 55 | Acne Conglobata | 25.4% |
| 56 | Urticaria Pigmentosa | 25% |
| 57 | Dermatitis Herpetiformis | 25% |
| 58 | Dermatitis, Photoallergic | 25% |
| 59 | Panniculitis, Lupus Erythematosus | 24.7% |
| 60 | Acrodermatitis | 24.7% |
| 61 | Porokeratosis | 24.7% |
| 62 | Gianotti-Crosti Syndrome | 24.7% |
| 63 | Keratoderma, Palmoplantar | 24.7% |
| 64 | Carcinoma, Lobular | 23.7% |
| 65 | Necrobiosis Lipoidica Diabeticorum | 23.2% |
| 66 | Breast Cyst | 22.8% |
| 67 | Actinic keratosis | 22.8% |
| 68 | Diaper Rash | 22.7% |
| 69 | Digestive System Neoplasms | 22.2% |
| 70 | Endocrine Gland Neoplasms | 22.2% |
| 71 | Eye Neoplasms | 22.2% |
| 72 | Foot Diseases | 22.2% |
| 73 | Nervous System Neoplasms | 22.2% |
| 74 | Bone neoplasms | 21.4% |
| 75 | Skin Abnormalities | 21.4% |
| 76 | Skin Diseases, Infectious | 21.4% |
| 77 | Hematologic Neoplasms | 21.4% |
| 78 | Pigmentation Disorders | 21.4% |
| 79 | Dermatitis, Occupational | 21.1% |
| 80 | Lipomatosis | 21.1% |
| 81 | Pruritus | 21.1% |
| 82 | Splenic Neoplasms | 21.1% |
| 83 | Erythema | 21.1% |
| 84 | Necrolytic Migratory Erythema | 21.1% |
| 85 | Cutaneous Fistula | 21.1% |
| 86 | Nephrogenic Fibrosing Dermopathy | 21.1% |
| 87 | Nephrogenic Systemic Fibrosis | 21.1% |
| 88 | Anhidrosis | 20.9% |
| 89 | Cholesteatoma | 20.9% |
| 90 | Pressure Ulcer | 20.9% |
| 91 | Folliculitis | 20.9% |
| 92 | Foot Dermatoses | 20.9% |
| 93 | Gynecomastia | 20.9% |
| 94 | Hypertrichosis | 20.9% |
| 95 | Hypohidrosis | 20.9% |
| 96 | Hypotrichosis | 20.9% |
| 97 | Leg Ulcer | 20.9% |
| 98 | Miliaria | 20.9% |
| 99 | Parakeratosis | 20.9% |
| 100 | Parapsoriasis | 20.9% |
| 101 | Parathyroid Neoplasms | 20.9% |
| 102 | Peritoneal Neoplasms | 20.9% |
| 103 | Pityriasis | 20.9% |
| 104 | Psoriasis | 20.9% |
| 105 | Retroperitoneal Neoplasms | 20.9% |
| 106 | Thyroid Neoplasm | 20.9% |
| 107 | Sweet Syndrome | 20.9% |
| 108 | Hidradenitis | 20.9% |
| 109 | Onycholysis | 20.9% |
| 110 | Miliaria Rubra | 20.9% |
| 111 | Hyperpigmentation | 20.9% |
| 112 | Lichenoid Eruptions | 20.9% |
| 113 | Chloracne | 20.9% |
| 114 | Thyroid carcinoma | 20.9% |
| 115 | Lupus Erythematosus, Discoid | 20.7% |
| 116 | Xeroderma | 20.7% |
| 117 | Scleroderma, Limited | 20.7% |
| 118 | Erythema Induratum | 20.4% |
| 119 | Dermatitis, Allergic Contact | 20.3% |
| 120 | Papillon-Lefevre Disease | 20.1% |
| 121 | Mastocytosis | 20% |
| 122 | Mastocytoma | 19.1% |
| 123 | Tracheal Neoplasms | 19.1% |
| 124 | Erythema Infectiosum | 18.9% |
| 125 | Exanthema Subitum | 18.8% |
| 126 | Toxic Epidermal Necrolysis | 18.7% |
| 127 | Stevens-Johnson Syndrome | 18.7% |
| 128 | Erythema Nodosum | 18.4% |
| 129 | Dermatomyositis | 18.3% |
| 130 | Paraneoplastic Encephalomyelitis | 18.3% |
| 131 | Cutis Laxa | 18.1% |
| 132 | Pancreatic Neoplasm | 18% |
| 133 | Mammary Neoplasms, Experimental | 17.9% |
| 134 | Tinea Capitis | 17.5% |
| 135 | Onychomycosis | 17.5% |
| 136 | Ectodermal Dysplasia | 17.5% |
| 137 | Aplasia Cutis Congenita | 17.5% |
| 138 | Hyperkeratosis, Epidermolytic | 17.2% |
| 139 | Lichen Planus | 17.2% |
| 140 | Melanosis | 17.2% |
| 141 | Chloasma | 17.2% |
| 142 | Pityriasis Rosea | 17.2% |
| 143 | Pityriasis Rubra Pilaris | 17.2% |
| 144 | Vitiligo | 17.2% |
| 145 | Lichen Nitidus | 17.2% |
| 146 | Multiple Endocrine Neoplasia | 17% |
| 147 | Thyroid Nodule | 16.9% |
| 148 | Pseudoxanthoma Elasticum | 16.6% |
| 149 | Esophageal Neoplasms | 15.9% |
| 150 | Acantholysis | 15.8% |
| 151 | Ecthyma | 15.8% |
| 152 | Mouth Neoplasms | 15.8% |
| 153 | Pemphigoid, Benign Mucous Membrane | 15.8% |
| 154 | Pemphigus | 15.8% |
| 155 | Piedra | 15.8% |
| 156 | Sunburn | 15.8% |
| 157 | Central Nervous System Neoplasms | 15.8% |
| 158 | Vascular Neoplasms | 15.8% |
| 159 | Thymus Neoplasms | 15.8% |
| 160 | Granuloma Annulare | 15.6% |
| 161 | Argyria | 15.5% |
| 162 | Genital Neoplasms, Female | 15.5% |
| 163 | Hirsutism | 15.5% |
| 164 | Lactation Disorder | 15.5% |
| 165 | Mastitis | 15.5% |
| 166 | Urticaria | 15.5% |
| 167 | Acanthosis Nigricans | 15.4% |
| 168 | Alopecia Areata | 15.4% |
| 169 | Lentigo | 15.4% |
| 170 | Adiposis Dolorosa | 15.4% |
| 171 | Pruritus Vulvae | 15.4% |
| 172 | Pruritus Ani | 15.3% |
| 173 | Connective Tissue Diseases | 15% |
| 174 | Hamartoma | 15% |
| 175 | Neoplasms, Hormone-Dependent | 15% |
| 176 | Neoplasms, Multiple Primary | 15% |
| 177 | Paraneoplastic Syndromes | 15% |
| 178 | Precancerous Conditions | 15% |
| 179 | Neoplasms, Second Primary | 15% |
| 180 | Ichthyosis, X-Linked | 14.5% |
| 181 | Sjogren-Larsson Syndrome | 14.4% |
| 182 | Hidradenitis Suppurativa | 14.4% |
| 183 | Meningioma | 14.3% |
| 184 | Thymoma | 14.3% |
| 185 | Carcinoma, Pancreatic Ductal | 14.3% |
| 186 | Testicular Neoplasms | 14% |
| 187 | Behcet Syndrome | 14% |
| 188 | Tinea Pedis | 13.4% |
| 189 | Alopecia | 13% |
| 190 | Sweating, Gustatory | 13% |
| 191 | Androgenetic Alopecia | 13% |
| 192 | Auriculotemporal Syndrome | 13% |
| 193 | Multiple Endocrine Neoplasia Type 1 | 13% |
| 194 | insulinoma | 12.9% |
| 195 | Vipoma | 12.9% |
| 196 | Gastrinoma | 12.8% |
| 197 | Glucagonoma | 12.8% |
| 198 | Meningeal Neoplasms | 12.8% |
| 199 | Lice Infestations | 12.8% |
| 200 | Varicose Ulcer | 12.8% |
| 201 | Galactorrhea | 12.7% |
| 202 | Adrenal Gland Neoplasms | 12.7% |
| 203 | Gastrointestinal Neoplasms | 12.7% |
| 204 | Genital Neoplasms, Male | 12.7% |
| 205 | Liver neoplasms | 12.7% |
| 206 | Uveal Neoplasms | 12.7% |
| 207 | Dermatomycoses | 12.5% |
| 208 | Mucocutaneous Lymph Node Syndrome | 12.5% |
| 209 | Urologic Neoplasms | 12.5% |
| 210 | Skin Diseases, Bacterial | 12.5% |
| 211 | Acoustic Neuroma | 12.4% |
| 212 | Albinism | 12.4% |
| 213 | Drug Eruptions | 12.3% |
| 214 | Lipodystrophy | 12.3% |
| 215 | Sebaceous Gland Neoplasms | 12.3% |
| 216 | Spinal Neoplasms | 12.3% |
| 217 | Livedo Reticularis | 12.3% |
| 218 | Malignant Atrophic Papulosis | 12.3% |
| 219 | Bone Marrow Neoplasms | 12.3% |
| 220 | Myxoid cyst | 12.3% |
| 221 | Polyarteritis Nodosa | 12.2% |
| 222 | Takayasu Arteritis | 12.2% |
| 223 | Erythema Chronicum Migrans | 12.1% |
| 224 | Carcinoma 256, Walker | 11.9% |
| 225 | Palatal Neoplasms | 11.9% |
| 226 | Leukoplakia, Oral | 11.9% |
| 227 | Paraneoplastic Cerebellar Degeneration | 11.8% |
| 228 | Peutz-Jeghers Syndrome | 11.7% |
| 229 | Lichen Planus, Oral | 11.7% |
| 230 | Nose Neoplasms | 11.5% |
| 231 | Meningeal Carcinomatosis | 11.4% |
| 232 | Carcinoma, Ehrlich Tumor | 11.3% |
| 233 | Dermoid Cyst | 11.3% |
| 234 | Carcinoma, Lewis Lung | 11.3% |
| 235 | Hepatocellular Adenoma | 11.2% |
| 236 | Liver Neoplasms, Experimental | 11.2% |
| 237 | Leydig Cell Tumor | 11.1% |
| 238 | Cyst | 11.1% |
| 239 | Neoplastic Processes | 11.1% |
| 240 | Neoplastic Syndromes, Hereditary | 11.1% |
| 241 | Pregnancy Complications, Neoplastic | 11.1% |
| 242 | Mycetoma | 11% |
| 243 | Neoplasms, Experimental | 10.9% |
| 244 | Neoplasms, Neuroepithelial | 10.8% |
| 245 | Gliomatosis cerebri | 10.8% |
| 246 | Retinoblastoma | 10.8% |
| 247 | Optic Nerve Glioma | 10.6% |
| 248 | Medulloblastoma | 10.6% |
| 249 | Ear Neoplasms | 10.5% |
| 250 | Eyelid Neoplasms | 10.5% |
| 251 | Lung Neoplasms | 10.5% |
| 252 | Pleural Neoplasms | 10.5% |
| 253 | Nail-Patella Syndrome | 10.5% |
| 254 | Larva Migrans | 10.3% |
| 255 | Leishmaniasis | 10.3% |
| 256 | Molluscum Contagiosum | 10.3% |
| 257 | Porphyrias, Hepatic | 10.3% |
| 258 | Neuroectodermal Tumors | 10.3% |
| 259 | Angioedema | 10.3% |
| 260 | Melanoma, Experimental | 10.3% |
| 261 | Onchocerciasis | 10.2% |
| 262 | Brain Neoplasms | 10.2% |
| 263 | Salivary Gland Neoplasms | 10.2% |
| 264 | Spinal Cord Neoplasms | 10.2% |
| 265 | Tongue Neoplasms | 10.2% |
| 266 | Chromoblastomycosis | 10.1% |
| 267 | Dermatophytosis | 10.1% |
| 268 | Sporotrichosis | 10.1% |
| 269 | Tinea | 10.1% |
| 270 | Tinea Versicolor | 10.1% |
| 271 | Trichophytosis | 10.1% |
| 272 | Hyalohyphomycosis | 10.1% |
| 273 | Pituitary Adenoma | 10.1% |
| 274 | Pituitary Neoplasms | 10.1% |
| 275 | melanoma | 10.1% |
| 276 | Uterine Neoplasms | 10.1% |
| 277 | Vaginal Neoplasms | 10.1% |
| 278 | Vulvar Neoplasms | 10.1% |
| 279 | Uterine Cancer | 10.1% |
| 280 | Acute Generalized Exanthematous Pustulosis | 10.1% |
| 281 | Limbic Encephalitis | 10% |
| 282 | Fallopian Tube Neoplasms | 10% |
| 283 | Trophoblastic Neoplasms | 9.7% |
| 284 | Leukemia, Experimental | 9.7% |
| 285 | Prolactinoma | 9.5% |
| 286 | Growth Hormone-Secreting Pituitary Adenoma | 9.5% |
| 287 | Collagen Diseases | 9.5% |
| 288 | Erythroplasia | 9.5% |
| 289 | Follicular cyst | 9.5% |
| 290 | leukemia | 9.5% |
| 291 | Mixed Connective Tissue Disease | 9.5% |
| 292 | Mucocele | 9.5% |
| 293 | Neoplasms, Germ Cell and Embryonal | 9.5% |
| 294 | Neoplasms, Glandular and Epithelial | 9.5% |
| 295 | Pilonidal Cyst | 9.5% |
| 296 | Thyroglossal Cyst | 9.5% |
| 297 | Synovial Cyst | 9.5% |
| 298 | Mucinoses | 9.5% |
| 299 | Germ Cell Cancer | 9.5% |
| 300 | Aberrant Crypt Foci | 9.5% |
| 301 | Carcinosarcoma | 9.4% |
| 302 | Hemangiosarcoma | 9.4% |
| 303 | Leukemia L1210 | 9.4% |
| 304 | Leukemia P388 | 9.4% |
| 305 | lymphangiosarcoma | 9.4% |
| 306 | Adenoma, Acidophil | 9.3% |
| 307 | Ganglioneuroma | 9.3% |
| 308 | Glioma | 9.3% |
| 309 | Malignant Glioma | 9.3% |
| 310 | Bronchial Neoplasms | 9.3% |
| 311 | Multiple Pulmonary Nodules | 9.2% |
| 312 | Nephroblastoma | 9.2% |
| 313 | Leishmaniasis, Cutaneous | 9.1% |
| 314 | Eczema Herpeticum | 9.1% |
| 315 | Supratentorial Neoplasms | 9% |
| 316 | Fusariosis | 9% |
| 317 | Carcinoid Tumor | 9% |
| 318 | Endometrial Neoplasms | 9% |
| 319 | Neurilemmoma | 9% |
| 320 | Hutchinson's Melanotic Freckle | 9% |
| 321 | Melanoma, Amelanotic | 9% |
| 322 | Lambert-Eaton Myasthenic Syndrome | 8.9% |
| 323 | Sarcoma 180 | 8.9% |
| 324 | Sarcoma, Experimental | 8.9% |
| 325 | Pharyngeal Neoplasms | 8.8% |
| 326 | ovarian neoplasm | 8.7% |
| 327 | Warts | 8.7% |
| 328 | Choriocarcinoma | 8.6% |
| 329 | Neoplasms, Radiation-Induced | 8.6% |
| 330 | Astrocytoma | 8.6% |
| 331 | Ependymoma | 8.6% |
| 332 | oligodendroglioma | 8.6% |
| 333 | Ganglioglioma | 8.6% |
| 334 | gliosarcoma | 8.6% |
| 335 | Anaplastic astrocytoma | 8.6% |
| 336 | Anaplastic Oligodendroglioma | 8.6% |
| 337 | Central Nervous System Cysts | 8.6% |
| 338 | Adrenocortical carcinoma | 8.5% |
| 339 | Bile Duct Neoplasms | 8.5% |
| 340 | Basal cell carcinoma | 8.5% |
| 341 | Carcinoma, Papillary | 8.5% |
| 342 | Squamous cell carcinoma | 8.5% |
| 343 | Chondrosarcoma | 8.5% |
| 344 | Craniopharyngioma | 8.5% |
| 345 | Cystadenoma | 8.5% |
| 346 | gallbladder neoplasm | 8.5% |
| 347 | Intestinal Neoplasms | 8.5% |
| 348 | leiomyosarcoma | 8.5% |
| 349 | liposarcoma | 8.5% |
| 350 | Mesothelioma | 8.5% |
| 351 | Penile Neoplasms | 8.5% |
| 352 | Prostatic Neoplasms | 8.5% |
| 353 | Stomach Neoplasms | 8.5% |
| 354 | synovial sarcoma | 8.5% |
| 355 | Neuroectodermal Tumor, Melanotic | 8.5% |
| 356 | Angiomyolipoma | 8.5% |
| 357 | Clear Cell Sarcoma of Soft Tissue | 8.5% |
| 358 | Alveolar Soft Part Sarcoma | 8.5% |
| 359 | Neuroendocrine Tumors | 8.5% |
| 360 | Sarcoma, Myeloid | 8.5% |
| 361 | Carcinoma, Basal Cell | 8.5% |
| 362 | Hereditary Angioedema Type III | 8.5% |
| 363 | Hereditary Angioedema Types I and II | 8.5% |
| 364 | Brain Stem Neoplasms | 8.5% |
| 365 | Malignant Carcinoid Syndrome | 8.4% |
| 366 | Candidiasis, Chronic Mucocutaneous | 8.4% |
| 367 | Cutaneous Candidiasis | 8.4% |
| 368 | Dupuytren Contracture | 8.4% |
| 369 | Erysipelas | 8.4% |
| 370 | Serum Sickness | 8.4% |
| 371 | Staphylococcal Skin Infections | 8.4% |
| 372 | Variegate Porphyria | 8.4% |
| 373 | Acute intermittent porphyria | 8.4% |
| 374 | Porphyria Cutanea Tarda | 8.4% |
| 375 | Erythrasma | 8.4% |
| 376 | Polycythemia Vera | 8.3% |
| 377 | Arthritis, Psoriatic | 8.3% |
| 378 | CREST Syndrome | 8.3% |
| 379 | granulosa cell tumor | 8.3% |
| 380 | Carcinoma, Ovarian Epithelial | 8.3% |
| 381 | Glioblastoma | 8.3% |
| 382 | Neuroblastoma | 8.3% |
| 383 | Glioblastoma Multiforme | 8.3% |
| 384 | Choroid Plexus Papilloma | 8.2% |
| 385 | Leukemia, Radiation-Induced | 8.1% |
| 386 | Ganglioneuroblastoma | 8.1% |
| 387 | Mesoblastic Nephroma | 8% |
| 388 | Cystadenocarcinoma | 8% |
| 389 | Fibrosarcoma | 8% |
| 390 | Osteosarcoma | 8% |
| 391 | Mucoepidermoid Carcinoma | 8% |
| 392 | Opsoclonus-Myoclonus Syndrome | 7.9% |
| 393 | Adenofibroma | 7.8% |
| 394 | Fibroadenoma | 7.8% |
| 395 | Malignant Fibrous Histiocytoma | 7.8% |
| 396 | Angioedemas, Hereditary | 7.6% |
| 397 | Hypopharyngeal Neoplasms | 7.6% |
| 398 | Pleural Effusion, Malignant | 7.6% |
| 399 | Hypopharyngeal Cancer | 7.6% |
| 400 | Bowen's Disease | 7.6% |
| 401 | Epidermodysplasia Verruciformis | 7.6% |
| 402 | Herpes Labialis | 7.6% |
| 403 | Paraganglioma | 7.6% |
| 404 | Rhabdomyosarcoma | 7.6% |
| 405 | Giant Cell Tumor of Bone | 7.6% |
| 406 | Adenomatous Polyposis Coli | 7.6% |
| 407 | Laryngeal neoplasm | 7.5% |
| 408 | Diabetic Foot | 7.5% |
| 409 | Tuberous Sclerosis | 7.5% |
| 410 | Parotid Neoplasms | 7.5% |
| 411 | Prostatic Neoplasms, Castration-Resistant | 7.5% |
| 412 | Nelson Syndrome | 7.4% |
| 413 | Staphylococcal Scalded Skin Syndrome | 7.4% |
| 414 | Leukemia, Plasma Cell | 7.4% |
| 415 | Cartilage Diseases | 7.4% |
| 416 | Rheumatism | 7.4% |
| 417 | Chondromalacia | 7.4% |
| 418 | Renal Cell Carcinoma | 7.4% |
| 419 | Papillary Renal Cell Carcinoma | 7.4% |
| 420 | Dermatofibrosarcoma | 7.3% |
| 421 | Dermatofibrosarcoma Protuberans | 7.3% |
| 422 | Bladder Neoplasm | 7.2% |
| 423 | Kidney Neoplasm | 7.2% |
| 424 | Ureteral Neoplasms | 7.2% |
| 425 | Urethral Neoplasms | 7.2% |
| 426 | Leukoplakia | 7.1% |
| 427 | Lupus Erythematosus, Systemic | 7.1% |
| 428 | Lymphocele | 7.1% |
| 429 | Pancreatic Cyst | 7.1% |
| 430 | Overlap syndrome | 7.1% |
| 431 | Pheochromocytoma | 7.1% |
| 432 | Alveolar rhabdomyosarcoma | 7.1% |
| 433 | Tonsillar Neoplasms | 7.1% |
| 434 | Carcinoma, Endometrioid | 7% |
| 435 | Barrett Esophagus | 7% |
| 436 | Histiocytic Disorders, Malignant | 7% |
| 437 | Mediastinal Cyst | 7% |
| 438 | Neoplasm Invasiveness | 7% |
| 439 | Neoplasm Metastasis | 7% |
| 440 | Neoplasm Recurrence, Local | 7% |
| 441 | Parovarian Cyst | 7% |
| 442 | Pericardial Cyst | 7% |
| 443 | Thymic Cyst | 7% |
| 444 | Carcinogenesis | 7% |
| 445 | Metastasis | 7% |
| 446 | Cerebellar Neoplasms | 7% |
| 447 | Myelitis, Transverse | 7% |
| 448 | Lymphomatoid Granulomatosis | 7% |
| 449 | Adenoma | 7% |
| 450 | Ameloblastoma | 7% |
| 451 | Angiokeratoma | 7% |
| 452 | carbuncle | 7% |
| 453 | Carcinoma | 7% |
| 454 | Chordoma | 7% |
| 455 | Hemangioma | 7% |
| 456 | hemangiopericytoma | 7% |
| 457 | Lymphangioma | 7% |
| 458 | Mesenchymoma | 7% |
| 459 | Nevus | 7% |
| 460 | Teratoma | 7% |
| 461 | Hepatoblastoma | 7% |
| 462 | Mixed Tumor, Mullerian | 7% |
| 463 | Germinoma | 7% |
| 464 | Teratocarcinoma | 7% |
| 465 | Angiofibroma | 7% |
| 466 | Scleromyxedema | 7% |
| 467 | Sarcoma | 7% |
| 468 | Epithelioma | 7% |
| 469 | Carcinoid Heart Disease | 6.9% |
| 470 | Composite Lymphoma | 6.7% |
| 471 | Giant Cell Arteritis | 6.6% |
| 472 | Temporal Arteritis | 6.6% |
| 473 | Basal Cell Nevus Syndrome | 6.5% |
| 474 | Nasopharyngeal carcinoma | 6.5% |
| 475 | Condylomata Acuminata | 6.5% |
| 476 | Furunculosis | 6.4% |
| 477 | furuncle | 6.4% |
| 478 | Cecal Neoplasms | 6.4% |
| 479 | Duodenal Neoplasms | 6.4% |
| 480 | Impetigo | 6.4% |
| 481 | Hydatidiform Mole | 6.3% |
| 482 | Blastomycosis | 6.3% |
| 483 | HIV-Associated Lipodystrophy Syndrome | 6.2% |
| 484 | Neurofibrosarcoma | 6.2% |
| 485 | Appendiceal Neoplasms | 6% |
| 486 | Colonic Neoplasms | 6% |
| 487 | Rectal Neoplasms | 6% |
| 488 | Endometrial Stromal Sarcoma | 5.8% |
| 489 | Adenocarcinoma | 5.7% |
| 490 | Carcinoma in Situ | 5.7% |
| 491 | Carcinoma, Transitional Cell | 5.7% |
| 492 | Phyllodes Tumor | 5.7% |
| 493 | Dysgerminoma | 5.7% |
| 494 | Hemangioendothelioma | 5.7% |
| 495 | Lipoma | 5.7% |
| 496 | Myoma | 5.7% |
| 497 | Myxoma | 5.7% |
| 498 | Neuroma | 5.7% |
| 499 | Papilloma | 5.7% |
| 500 | Pseudomyxoma Peritonei | 5.7% |
| 501 | Seminoma | 5.7% |
| 502 | Papillomatosis | 5.7% |
| 503 | Angiolipoma | 5.7% |
| 504 | Myelolipoma | 5.7% |
| 505 | Neoplasms, Bone Tissue | 5.7% |
| 506 | Neoplasms, Fibrous Tissue | 5.7% |
| 507 | Smooth Muscle Tumor | 5.7% |
| 508 | Adenomatosis, Pulmonary | 5.7% |
| 509 | Adenomatous Polyps | 5.7% |
| 510 | Carcinoma, Large Cell | 5.7% |
| 511 | Carcinoma, Small Cell | 5.7% |
| 512 | Desmoplastic Small Round Cell Tumor | 5.7% |
| 513 | Chondroma | 5.7% |
| 514 | Enchondroma | 5.7% |
| 515 | Rhinoscleroma | 5.7% |
| 516 | Nasopharyngeal Neoplasms | 5.7% |
| 517 | Colorectal Neoplasms | 5.6% |
| 518 | Lymphoma | 5.6% |
| 519 | Lymphangioleiomyomatosis | 5.6% |
| 520 | Denys-Drash Syndrome | 5.5% |
| 521 | Corpus Luteum Cyst | 5.5% |
| 522 | Ovarian Cysts | 5.5% |
| 523 | Mesenteric Panniculitis | 5.3% |
| 524 | Panniculitis, Peritoneal | 5.3% |
| 525 | Tietze's Syndrome | 5.3% |
| 526 | Orbital Cellulitis | 5.3% |
| 527 | Myxedema | 5.2% |
| 528 | Pancreatic Pseudocyst | 5.2% |
| 529 | Plasmacytoma | 5.2% |
| 530 | Adenoid Cystic Carcinoma | 5.1% |
| 531 | fibroma | 5.1% |
| 532 | Fibromatosis | 5.1% |
| 533 | Osteoblastoma | 5.1% |
| 534 | Osteoma | 5.1% |
| 535 | Rhabdomyoma | 5.1% |
| 536 | Chondromatosis | 5.1% |
| 537 | Adenocarcinoma, Clear Cell | 5.1% |
| 538 | Cholangiocarcinoma | 5.1% |
| 539 | Cervical Intraepithelial Neoplasia | 5.1% |
| 540 | Hemangioblastoma | 5.1% |
| 541 | Lymphoma, Extranodal NK-T-Cell | 5.1% |
| 542 | Malignant histiocytosis | 5.1% |
| 543 | Lymphatic Metastasis | 5.1% |
| 544 | Neoplasms, Unknown Primary | 5.1% |
| 545 | Leukemic Infiltration | 5.1% |
| 546 | Histiocytic sarcoma | 5.1% |
| 547 | Neoplasm Micrometastasis | 5.1% |
| 548 | Paranasal Sinus Neoplasms | 5% |
| 549 | Anus Neoplasms | 5% |
| 550 | Sigmoid Neoplasms | 5% |
| 551 | Menkes Kinky Hair Syndrome | 4.9% |
| 552 | Fibromatosis, Aggressive | 4.8% |
| 553 | Fibromatosis, Abdominal | 4.8% |
| 554 | Klatskin Tumor | 4.8% |
| 555 | Maxillary Sinus Neoplasms | 4.7% |
| 556 | Choledochal Cyst | 4.7% |
| 557 | Cellulitis | 4.6% |
| 558 | Acanthoma | 4.3% |
| 559 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 560 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 561 | Osteochondritis | 4.2% |
| 562 | Polymyalgia Rheumatica | 4.2% |
| 563 | Osteogenesis Imperfecta | 4.1% |
| 564 | Hodgkin Disease | 4.1% |
| 565 | Keloid | 4.1% |
| 566 | Lymphoma, Non-Hodgkin | 4.1% |
| 567 | Polycystic Ovary Syndrome | 4% |
| 568 | Mastocytosis, Systemic | 3.8% |
| 569 | Leukemia, Myeloid, Chronic-Phase | 3.8% |
| 570 | Rheumatoid Arthritis | 3.5% |
| 571 | Juvenile arthritis | 3.5% |
| 572 | Sturge-Weber Syndrome | 3.4% |
| 573 | Cell Transformation, Viral | 3.4% |
| 574 | Gastrointestinal Stromal Tumors | 3.4% |
| 575 | Noonan Syndrome | 3.4% |
| 576 | Primary amyloidosis | 3.4% |
| 577 | Hemangioma, Cavernous | 3.4% |
| 578 | Rheumatoid Nodule | 3.4% |
| 579 | Leukemia, T-Cell | 3.4% |
| 580 | Leukemia, B-Cell | 3.4% |
| 581 | Lupus Nephritis | 3.3% |
| 582 | neurofibroma | 3.3% |
| 583 | Lymphoma, Follicular | 3.3% |
| 584 | T-Cell Lymphoma | 3.3% |
| 585 | Mantle cell lymphoma | 3.3% |
| 586 | Marfan Syndrome | 3% |
| 587 | Laryngomalacia | 3% |
| 588 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 589 | Leukemia, Large Granular Lymphocytic | 3% |
| 590 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 591 | Lymphoma, T-Cell, Cutaneous | 3% |
| 592 | Lymphoma, AIDS-Related | 3% |
| 593 | Enteropathy-Associated T-Cell Lymphoma | 3% |
| 594 | Primary Effusion Lymphoma | 3% |
| 595 | Pectus carinatum | 3% |
| 596 | Homocystinuria | 2.9% |
| 597 | Felty Syndrome | 2.8% |
| 598 | Bronchomalacia | 2.8% |
| 599 | Tracheomalacia | 2.8% |
| 600 | Mycosis Fungoides | 2.8% |
| 601 | Lymphomatoid Papulosis | 2.8% |
| 602 | Plasmablastic lymphoma | 2.8% |
| 603 | Waldenstrom Macroglobulinemia | 2.5% |
| 604 | Multiple Myeloma | 2.5% |
| 605 | Rheumatoid Vasculitis | 2.4% |
| 606 | Mucopolysaccharidosis III | 2.3% |
| 607 | Zollinger-Ellison syndrome | 2.2% |
| 608 | Burkitt Lymphoma | 2.1% |
| 609 | Sicca Syndrome | 2.1% |
| 610 | Sjogren's Syndrome | 2.1% |
| 611 | Sezary Syndrome | 2% |
| 612 | Radicular Cyst | 2% |
| 613 | Mucopolysaccharidosis II | 1.6% |
| 614 | Lupus Vasculitis, Central Nervous System | 1.5% |